secukinumab,adalimumab
novartis,abbvie
['adalimumab', 'axspa', 'secukinumab']
secukinumab and adalimumab biosimilar seem to be equally effective in terms of preventing progression of radiologic axial #spondyloarthritis
#visualabstract #rheumatology #eular2023 
Here, is the CLINICAL TRIAL OF THE DAY 
The interesting clinical study with impact on future clinical practice 
// Our editor's opinion only //